Tegretol-XR Related Published Studies
Well-designed clinical trials related to Tegretol-XR (Carbamazepine)
Evaluation of the efficacy and safety of pregabalin, venlafaxine, and
carbamazepine in patients with painful diabetic peripheral neuropathy. A
randomized, double-blind trial. [2014]
Population pharmacokinetics of carbamazepine in elderly patients. [2012]
The effect of levetiracetam monotherapy on subjective sleep quality and objective sleep parameters in patients with epilepsy: compared with the effect of carbamazepine-CR monotherapy. [2011.05]
Pregabalin effect on steady-state pharmacokinetics of carbamazepine, lamotrigine, phenobarbital, phenytoin, topiramate, valproate, and tiagabine. [2011.02]
Carbamazepine coadministration with an oral contraceptive: effects on steroid pharmacokinetics, ovulation, and bleeding. [2011.02]
Cognitive and behavioral effects of lamotrigine and carbamazepine monotherapy in patients with newly diagnosed or untreated partial epilepsy. [2011.01]
Effects of oxcarbazepine and carbamazepine on driving ability: a double-blind, randomized crossover trial with healthy volunteers. [2010.05]
No pharmacokinetic interaction between lacosamide and carbamazepine in healthy volunteers. [2010.04]
Antiepileptic drugs and quality of life in the elderly: results from a randomized double-blind trial of carbamazepine and lamotrigine in patients with onset of epilepsy in old age. [2010.03]
A blinded, randomized comparison of immediate-release and extended-release carbamazepine capsules in manic and depressed bipolar subjects. [2010.02]
Carbamazepine but not pregabalin impairs eye control: a study on acute objective CNS side effects in healthy volunteers. [2010.02]
A blinded, randomized comparison of immediate-release and extended-release
carbamazepine capsules in manic and depressed bipolar subjects. [2010]
[A prospective, open, controlled and randomised study of clobazam versus carbamazepine in patients with frequent episodes of Rolandic epilepsy] [2009.12.01]
Effects of the P-glycoprotein inducer carbamazepine on fexofenadine pharmacokinetics. [2009.12]
Cardiac function and antiepileptic drug treatment in the elderly: a comparison between lamotrigine and sustained-release carbamazepine. [2009.08]
Treatment of subjective tinnitus: a comparative clinical study of intratympanic steroid injection vs. oral carbamazepine. [2009.06]
Adverse event load in bipolar participants receiving either carbamazepine immediate-release or extended-release capsules: a blinded, randomized study. [2009.05]
Effects of ketoconazole and carbamazepine on lapatinib pharmacokinetics in healthy subjects. [2009.04]
Randomised controlled study-efficacy of clonidine versus carbamazepine in children with ADHD. [2009.04]
The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy. [2009.03]
Comparison of add-on valproate and primidone in carbamazepine-unresponsive patients with partial epilepsy. [2009.03]
Bipolar I and II disorder residual symptoms: Oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial. [2009.02.01]
Comparison of carbamazepine and lithium in treatment of bipolar disorder: a systematic review of randomized controlled trials. [2009.01]
[Efficacy of carbamazepine combined with flunarizine hydrochloride for treating tinnitus] [2008.11]
The effectiveness of carbamazepine in unipolar depression: a double-blind, randomized, placebo-controlled study. [2008.07]
Erythrocyte and plasma fatty acid profiles in patients with epilepsy: does carbamazepine affect omega-3 fatty acid concentrations? [2008.02]
Exposure-response analysis reveals that clinically important toxicity difference can exist between bioequivalent carbamazepine tablets. [2008.01]
The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures. [2007.12]
Neuropsychological and neurophysiologic effects of carbamazepine and levetiracetam. [2007.11.27]
Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy. [2007.11]
The effects on cognitive function and behavioral problems of topiramate compared to carbamazepine as monotherapy for children with benign rolandic epilepsy. [2007.09]
Lack of Pharmacokinetic Interaction of Levetiracetam on Carbamazepine, Valproic Acid, Topiramate, and Lamotrigine in Children with Epilepsy. [2007.07.25]
An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. [2007.07]
Side effects of phenobarbital and carbamazepine in childhood epilepsy: randomised controlled trial. [2007.06.09]
Adjunctive herbal medicine with carbamazepine for bipolar disorders: A double-blind, randomized, placebo-controlled study. [2007.04]
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. [2007.03.24]
Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. [2007.02.06]
Biopharmaceutical characterization of carbamazepine immediate release tablets. In vitro-in vivo comparison. [2007]
Efficacy of carbamazepine and valproate as monotherapy for early epilepsy and single seizures. [2006.11.28]
Bronchial asthma as neurogenic paroxysmal inflammatory disease: A randomized trial with carbamazepine. [2006.11]
Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies. [2006.07]
Influence of activated charcoal on the pharmacokinetics and the clinical features of carbamazepine poisoning. [2006.07]
Folic acid supplementation reduces the development of some blood cell abnormalities in children receiving carbamazepine. [2006.02]
Lamotrigine versus carbamazepine monotherapy for epilepsy. [2006.01.25]
Modulation of serum concentrations of melatonin by carbamazepine and valproate. [2006.01]
Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients. [2006]
The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults. [2005.12]
A comparative study of vigabatrin vs. carbamazepine in monotherapy of newly diagnosed partial seizures in children. [2005.09]
Oxcarbazepine versus carbamazepine in the treatment of alcohol withdrawal. [2005.09]
The comparative evaluation of gabapentin and carbamazepine for pain management in Guillain-Barre syndrome patients in the intensive care unit. [2005.07]
[Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study] [2005.07]
New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. [2005.06.14]
Effect of probenecid on the pharmacokinetics of carbamazepine in healthy subjects. [2005.06]
Induction of the metabolism of etizolam by carbamazepine in humans. [2005.05]
Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. [2005.03]
Effects of add-on melatonin administration on antioxidant enzymes in children with epilepsy taking carbamazepine monotherapy: a randomized, double-blind, placebo-controlled trial. [2004.12]
Impact of cytochrome P-450 inhibition by cimetidine and induction by carbamazepine on the kinetics of hypericin and pseudohypericin in healthy volunteers. [2004.11]
Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers. [2004.11]
[A randomised open trial comparing monotherapy with topiramate versus carbamazepine in the treatment of paediatric patients with recently diagnosed epilepsy] [2004.08.01]
Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy. [2004.08]
Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch. [2004.06]
The effect of carbamazepine on human corticomuscular coherence. [2004.05]
A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. [2004.04]
Treatment of alcohol withdrawal: chlormethiazole vs. carbamazepine and the effect on memory performance--a pilot study. [2004.03]
A multicenter, placebo-controlled, double-blind study of efficacy of a new form of carbamazepine (Carbatrol) in refractory epileptic patients. [2004.03]
Topiramate, carbamazepine, and valproate monotherapy: double-blind comparison in children with newly diagnosed epilepsy. [2004.02]
Carbamazepine markedly reduces serum concentrations of simvastatin and simvastatin acid. [2004.02]
Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy. [2003.12]
Effect of concomitantly administered honey on the pharmacokinetics of carbamazepine in healthy volunteers. [2003.09]
Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects. [2003.04]
Comparison of desipramine or carbamazepine to placebo for crack cocaine-dependent patients. [2003.03]
Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. [2003.03]
Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients. [2003.02]
Intravenous immunoglobulin in the treatment of primary trigeminal neuralgia refractory to carbamazepine: a study protocol [ISRCTN33042138]. [2003.01.30]
Carbamazepine versus phenobarbitone monotherapy for epilepsy. [2003]
[The comparison of tianeptine and carbamazepine in benzodiazepines withdrawal symptoms] [2002.11]
Gabapentin and lamotrigine in Indian patients of partial epilepsy refractory to carbamazepine. [2002.09]
Carbamazepine: a bioequivalence study and limited sampling modeling. [2002.09]
Carbamazepine in the treatment of cocaine dependence: subtyping by affective disorder. [2002.08]
Reanalysis of carbamazepine and carbamazepine-epoxide pharmacokinetics after multiple dosing of extended release formulation. [2002.05]
Time course of lamotrigine de-induction: impact of step-wise withdrawal of carbamazepine or phenytoin. [2002.05]
The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. [2002.05]
Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers. [2002.05]
Inter-episodic morbidity and drop-out under carbamazepine and lithium in the maintenance treatment of bipolar disorder. [2002.04]
Carbamazepine augmentation for schizophrenia: how good is the evidence? [2002.03]
Effect of an acidic beverage (Coca-Cola) on the pharmacokinetics of carbamazepine in healthy volunteers. [2002.01]
A comparative study of the effects of carbamazepine and the NMDA receptor antagonist remacemide on road tracking and car-following performance in actual traffic. [2002.01]
Carbamazepine versus phenytoin monotherapy for epilepsy. [2002]
Effects of carbamazepine on dexamethasone suppression and sleep electroencephalography in borderline personality disorder. [2002]
Post-dexamethasone cortisol correlates with severity of depression before and during carbamazepine treatment in women but not men. [2001.11]
A pilot randomized trial of carbamazepine for behavioral symptoms in treatment-resistant outpatients with Alzheimer disease. [2001.09]
A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy. [2001.08]
Comparative cognitive effects of carbamazepine and gabapentin in healthy senior adults. [2001.06]
Differential cognitive and behavioral effects of carbamazepine and lamotrigine. [2001.05.08]
The influence of food on the bioavailability of a twice-daily controlled release carbamazepine formulation. [2001.02]
The response of neuropathic pain and pain in complex regional pain syndrome I to carbamazepine and sustained-release morphine in patients pretreated with spinal cord stimulation: a double-blinded randomized study. [2001.02]
Drug-drug interaction studies with mirtazapine and carbamazepine in healthy male subjects. [2001.01]
Changes in color vision after a single dose of vigabatrin or carbamazepine in healthy volunteers. [2001.01]
Increased seizures after discontinuing carbamazepine: results from the gabapentin monotherapy trial. [2000.12]
Tiagabine versus phenytoin and carbamazepine as add-on therapies: effects on abilities, adjustment, and mood. [2000.12]
Effects of short-term lamotrigine treatment on pharmacokinetics of carbamazepine. [2000.11]
|